RPG Life Sciences surges on receiving EUGMP certification for formulation facility at Ankleshwar

06 Apr 2016 Evaluate

RPG Life Sciences is currently trading at Rs. 257.80, up by 24.30 points or 10.41% from its previous closing of Rs. 233.50 on the BSE.

The scrip opened at Rs. 253.00 and has touched a high and low of Rs. 259.90 and Rs. 246.60 respectively. So far 73,000 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 8 has touched a 52 week high of Rs. 360.60 on 03-Dec-2015 and a 52 week low of Rs. 130.50 on 24-Apr-2015.

Last one week high and low of the scrip stood at Rs. 259.90 and Rs. 221.00 respectively. The current market cap of the company is Rs. 426.47 crore.

The promoters holding in the company stood at 66.79% while Institutions and Non-Institutions held 0.28% and 32.93% respectively.

RPG Life Sciences has received GMP certification from Bavarian Authority, a competent authority in Germany, as per EUGMP standards for its formulation facility at Ankleshwar in Gujarat. The Bavarian authority conducted the audit of the manufacturing facility in early March 2016.The certification will help the company in boosting sales by expanding its geographical presence in the European markets.

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.


RPG Life Sciences Share Price

1494.55 39.70 (2.73%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.